Graft copolymer polyelectrolyte complexes for delivery of cationic antimicrobial peptides

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 9, 2013, Pages 2548-2558

  Niece, Krista L ^a   Vaughan, Asa D ^a   Devore, David I ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

cationic antimicrobial peptides; graft copolymers; human plasma degradation; poly(alkylacrylic acid); polyelectrolyte complexes

Indexed keywords

ANTI-MICROBIAL ACTIVITY; CARBODIIMIDE COUPLINGS; CATIONIC ANTIMICROBIAL PEPTIDES; HUMAN PLASMAS; HYDROLYTIC DEGRADATION; MICROBIOLOGICAL ASSAYS; POLY(ALKYLACRYLIC ACID); POLYELECTROLYTE COMPLEXES;

BACTERIA; GRAFT COPOLYMERS; MEDICAL APPLICATIONS; PLASMA (HUMAN); POLYELECTROLYTES;

PEPTIDES;

ALKYL GROUP; COPOLYMER; CYANAMIDE; NANOPARTICLE; POLY(ALKYLACRYLIC ACID); POLYELECTROLYTE; POLYETHERAMINE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; HUMAN; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PLASMA; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; STATIC ELECTRICITY; ZETA POTENTIAL;

CATIONIC ANTIMICROBIAL PEPTIDES; GRAFT COPOLYMERS; HUMAN PLASMA DEGRADATION; POLY(ALKYLACRYLIC ACID); POLYELECTROLYTE COMPLEXES;

ANTIMICROBIAL CATIONIC PEPTIDES; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; ELECTROLYTES; HUMANS; MATERIALS TESTING; NANOPARTICLES; PARTICLE SIZE; POLYMERS; STAPHYLOCOCCUS AUREUS;

EID: 84880582546     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34555     Document Type: Article

References (47)

1. Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M,. Use of antimicrobial peptides against microbial biofilms: Advantages and limits. Curr Med Chem 2011; 18: 256-279.
2. Oyston PCF, Fox MA, Richards SJ, Clark GC,. Novel peptide therapeutics for treatment of infections. J Med Microbiol 2009; 58: 977-987.
3. Chen L, Wen Y-M,. The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci 2011; 3: 66-73.
4. Leung K-P, Abercrombie JJ, Campbell TM, Gilmore KD, Bell CA, Faraj JA, DeLuca PP,. Antimicrobial peptides for plaque control. Adv Dent Res 2009; 21: 57-62.
5. Schweizer F,. Cationic amphiphilic peptides with cancer-selective toxicity. Eur J Pharmacol 2009; 625: 190-194.
6. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M,. Synthetic therapeutic peptides: Science and market. Drug Discov Today 2010; 15: 40-56.
7. Yeung A, Gellatly S, Hancock R,. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 2011; 68: 2161-2176.
8. Davies D,. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003; 2: 114-122.
9. Miclau T, Schmidt A, Wenke J, Webb L, Harro J, Prabhakara R, Shirtliff M., Infection. J Orthop Trauma 2010; 24: 583-586.
10. Otto M,. Bacterial evasion of antimicrobial peptides by biofilm formation. In: Shafer WM, editor. Antimicrobial Peptides and Human Disease. Berlin, Heidelberg: Springer; 2006. p 251-258.
11. Park S, Park Y, Hahm K,. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci 2011; 2011: 5971-5992.
12. Zhang L, Pornpattananangkul D, Hu CMJ, Huang CM,. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 2010; 17: 585-594.
13. Smith AW,. Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 2005; 57: 1539-1550.
14. Drulis-Kawa Z, Dorotkiewicz-Jach A,. Liposomes as delivery systems for antibiotics. Int J Pharma 2010; 387: 187-198.
15. Tamilvanan S, Venkateshan N, Ludwig A,. The potential of lipid and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release 2008; 128: 2-22 [1873-4995 (Electronic)].
16. Couvreur P, Fattal E, Andremont A,. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharma Res 1991; 8: 1079-1086.
17. Cooper CL, Dubin PL, Kayitmazer AB, Turksen S., Polyelectrolyte-protein complexes. Curr Opin Colloid Interface Sci 2005; 10: 52-78.
18. Haag R,. Supramolecular drug-delivery systems based on polymeric core-shell architectures. Angew Chem Int Ed 2004; 43: 278-282.
19. Hales K, Pochan DJ,. Using polyelectrolyte block copolymers to tune nanostructure assembly. Curr Opin Colloid Interface Sci 2006; 11: 330-336.
20. Gupta K, Singh VP, Kurupati RK, Mann A, Ganguli M, Gupta YK, Singh Y, Saleem K, Pasha S, Maiti S,. Nanoparticles of cationic chimeric peptide and sodium polyacrylate exhibit striking antinociception activity at lower dose. J Controlled Release 2009; 134: 47-54.
21. Bysell H, Hansson P, Malmsten M,. Effect of charge density on the interaction between cationic peptides and oppositely charged microgels. J Phys Chem B 2010; 114: 7207-7215.
22. Shukla A, Fleming KE, Chuang HF, Chau TM, Loose CR, Stephanopoulos GN, Hammond PT,. Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials 2010; 31: 2348-2357.
23. Akagi T, Baba M, Akashi M,. Preparation of nanoparticles by the self-organization of polymers consisting of hydrophobic and hydrophilic segments: Potential applications. Polymer 2007; 48: 6729-6747.
24. Costache AD, Sheihet L, Zaveri K, Knight DD, Kohn J,. Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: A computational modeling approach. Mol Pharma 2009; 6: 1620-1627.
25. Jones RA, Cheung CY, Black FE, Zia JK, Stayton PS, Hoffman AS, Wilson MR., Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem J 2003; 372: 65-75.
26. Pack DW, Hoffman AS, Pun S, Stayton PS,. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005; 4: 581-593.
27. Mishra S, Peddada LY, Devore DI, Roth CM,. Poly(alkylene oxide) copolymers for nucleic acid delivery. Acc Chem Res 2012; 45: 1057-1066.
28. Faraj J, Dorati R, Schoubben A, Worthen D, Selmin F, Capan Y, Leung K, DeLuca P,. Development of a peptide-containing chewing gum as a sustained release antiplaque antimicrobial delivery system. AAPS Pharm Sci Tech 2007; 8: E177-E185.
29. Peddada LY, Harris NK, Devore DI, Roth CM,. Novel graft copolymers enhance in vitro delivery of antisense oligonucleotides in the presence of serum. J Controlled Release 2009; 140: 134-140.
30. Braun D, Cherdron H, Rehahn M, Ritter H, Voit B,. Polymer Synthesis: Theory and Practice. Berlin: Springer; 2005.
31. Barry A, Craig W, Nadler H, Reller LB, Sanders C, Swenson J,. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. Clinical and Laboratory Standards Institute 1999(M26-A), Wayne, PA.
32. Manning GS,. The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides. Quarter Rev Biophys 1978; 11: 179-246.
33. McGhee J, von Hippel PH,. Theoretical aspects of DNA-protein interactions: Co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. J Mol Biol 1974; 86: 469-489.
34. Semlali A, Leung KP, Curt S, Rouabhia M,. Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human beta-defensin, and cytokine expression by engineered human oral mucosa. Peptides 2011; 32: 1873-5169 (Electronic).
35. Zavascki AP, Goldani LZ, Li J, Nation RL,. Polymyxin B for the treatment of multidrug-resistant pathogens: A critical review. J Antimicrob Chemother 2007; 60: 1206-1215.
36. Williams RL, Sroussi HY, Abercrombie JJ, Leung K, Marucha PT,. Synthetic decapeptide reduces bacterial load and accelerates healing in the wounds of restraint-stressed mice. Brain Behav Immun 2012; 26: 588-596.
37. Deresinski S., Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005; 40: 562-573.
38. Belley A, Neesham-Grenon E, McKay G, Arhin FF, Harris R, Beveridge T, Parr TR Jr, Moeck G,. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob Agents Chemother 2009; 53: 918-925.
39. Fenley MO, Russo C, Manning GS,. A theoretical assessment of the oligolysine model for ionic interactions in protein-DNA complexes. J Phys Chem B 2011; 115: 9864-9872.
40. Mascotti DP, Lohman TM,. Thermodynamic extent of counterion release upon binding oligolysines to single-stranded nucleic acids. Proc Natl Acad Sci 1990; 87: 3142.
41. Bagheri M, Beyermann M, Dathe M,. Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob Agents Chemother 2009; 53: 1132-1141.
42. Williams R, Lim S, Onyuksel H, Marucha P,. Sterically stabilized phospholipid micelles reduce activity of a candidate antimicrobial wound healing adjunct. Int J Peptide Res Ther 2012; 18: 195-203.
43. Reith D, Müller B, Müller-Plathe F, Wiegand S,. How does the chain extension of poly (acrylic acid) scale in aqueous solution? A combined study with light scattering and computer simulation. J Chem Phys 2002; 116: 9100-9107.
44. Sedlák M,. Homopolymer self-assembly into stable nanoparticles: Concerted action of hydrophobic association and hydrogen bonding in thermoresponsive Poly(alkylacrylic acid)s. J Phys Chem B 2012; 116: 2356-2364.
45. Barrat J-L, Joanny F,. Theory of Polyelectrolyte Solutions. Advances in Chemical Physics. New York: Wiley; 2007. p 1-66.
46. Manning GS,. Limiting laws and counterion condensation in polyelectrolyte solutions. 7. Electrophoretic mobility and conductance. J Phys Chem 1981; 85: 1506-1515.
47. Gregory J, Barany S,. Adsorption and flocculation by polymers and polymer mixtures. Adv Colloid Interface Sci 2011; 169: 1-12.